|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
<b>Objective:</b> The study tested whether cardiovascular corresponding LPA risk genotypes improve pre-eclampsia and coronary heart disease (CHD) risk prediction beyond conventional risk factors.
|
31113255 |
2019 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Coronary artery disease is the most common cause of death globally and is linked to a number of risk factors including serum low density lipoprotein, high density lipoprotein, triglycerides and lipoprotein(a).
|
29713054 |
2018 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Coronary heart disease risk correlates directly with plasma concentrations of lipoprotein(a) (Lp(a)), a low-density lipoprotein-like particle distinguished by the presence of the glycoprotein apolipoprotein(a) (apo(a)), which is bound to apolipoprotein B-100 (apoB-100) by disulfide bridges.
|
2976021 |
1988 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) is a plasma particle which is considered to be a risk factor for the development of coronary heart disease.
|
10095988 |
1999 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has been considered to be a predictor of premature coronary heart disease and other cardiovascular diseases.
|
10098351 |
1999 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease.
|
10168548 |
1996 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a). A genetic risk factor for premature coronary heart disease.
|
1534588 |
1992 |
|
Coronary heart disease
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Lipoprotein (a) (Lp(a)) is a low density lipoprotein-like particle which contains the plasminogen-like apolipoprotein a. Lp(a) levels are elevated in patients with atherosclerotic coronary artery disease.
|
1824942 |
1991 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is an established risk factor for coronary disease and stroke, but mechanisms underlying this association are unknown.
|
21078622 |
2011 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
lipoprotein(a) [Lp(a)] level is an established risk factor for coronary artery disease and has been implicated in carotid artery disease (CAAD).
|
21127300 |
2011 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is a macromolecular complex found in human plasma that combines structural elements from the lipoprotein and blood clotting systems and that is associated with premature coronary heart disease and stroke.
|
2530631 |
1989 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has recently been recognized as an independent risk factor for coronary heart disease.
|
25604958 |
2015 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein (a) [Lp(a)] has attracted the interest of researchers and physicians due to its intriguing properties, including an intragenic multiallelic copy number variation in the LPA gene and the strong association with coronary heart disease (CHD).
|
27074913 |
2016 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein (a) [Lp(a)] is an independent but moderate, predictor for coronary heart disease (CHD) prevalence and severity.
|
28078997 |
2017 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a)[Lp(a)] is a risk factor for coronary heart diseases.
|
28192139 |
2017 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.
|
28700032 |
2017 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) is associated with left ventricular systolic dysfunction in a Chinese population of patients with hypertension and without coronary artery disease.
|
28883849 |
2017 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.
|
29246959 |
2017 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) (Lp[a]) is proatherosclerotic and prothrombotic, causally related to coronary disease, and associated with other cardiovascular diseases.
|
29246963 |
2017 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein (a) as a Marker for Predicting the Presence and Severity of Coronary Artery Disease in Untreated Chinese Patients Undergoing Coronary Angiography.
|
29773088 |
2018 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) (Lp(a)) is a causal risk factor for cardiovascular disorders including coronary heart disease and calcific aortic valve stenosis.
|
29852400 |
2018 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
|
29960898 |
2018 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] is an enigmatic lipoprotein which has been identified as a causal risk factor for coronary heart disease and calcific aortic valve disease.
|
29990619 |
2018 |
|
Coronary heart disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein(a) [Lp(a)] has been classified as the most prevalent genetic risk factor for coronary artery disease and aortic valve stenosis.
|
30087087 |
2018 |
|
Coronary heart disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
|
30447089 |
2019 |